Which of the following best explains cryoablation’s safety advantage during EP procedures?

• A. Cryoablation heats tissue faster
• B. Cryomapping allows reversible testing of the effect on the arrhythmia circuit before creating permanent lesions
• C. Cryoablation cannot be used near the conduction system
• D. Cryomapping provides no safety advantage

Answer: (B)

Cryoablation’s safety edge comes from cryomapping, which lets you test the effect of cooling on the arrhythmia circuit and nearby conduction tissue without making a permanent lesion. By cooling to a mild temperature, tissue excitability and conduction are temporarily suppressed. If the arrhythmia behavior improves without causing an unintended block, you can proceed to create a permanent cryolesion. If a conduction disturbance appears, you can rewarm and function typically returns, avoiding lasting injury. This reversible testing is especially valuable when ablation is near the AV node or His-Purkinje system, where permanent damage would be problematic. So the safety advantage is the ability to test effects safely before committing to permanent tissue injury.